Clinical Chemistry
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

Clinical Chemistry 52: 737-739, 2006. First published February 2, 2006; 10.1373/clinchem.2005.057695
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Data Supplement
Right arrow All Versions of this Article:
clinchem.2005.057695v1
52/4/737    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Web of Science (1)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Krahn, J.
Right arrow Articles by Khajuria, A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Krahn, J.
Right arrow Articles by Khajuria, A.
Related Collections
Right arrow General Clinical Chemistry
Right arrow Drug Monitoring and Toxicology
(Clinical Chemistry. 2006;52:737-739.)
© 2006 American Association for Clinical Chemistry, Inc.

Technical Briefs

Osmolality Gaps: Diagnostic Accuracy and Long-Term Variability

John Krahna and Annu Khajuria

(Department of Clinical Biochemistry, St. Boniface General Hospital, and University of Manitoba Medical School, Winnipeg, Manitoba, Canada;

aaddress correspondence to this author at: St. Boniface General Hospital, Winnipeg, Manitoba, Canada R2H 2A6; fax 204-231-2656, e-mail jkrahn{at}sbgh.mb.ca)


Abstract

Background: The osmolal gap (OG) is a screening test for the detection of toxic volatiles such as methanol and ethylene glycol. We used mean values of patient data to assess the diagnostic accuracy and long-term stability of OG measurements.

Methods: In a prospective study period in 2003, all requests for volatiles had OGs calculated and quality-control samples were analyzed for OG. ROC curves were constructed to determine whether OG could predict the presence of toxic volatiles in serum. This was also done in a retrospective study for data from 1996 to 2004. Our laboratory database was searched for all emergency room patients for the period of 1996 to 2004 who had tests ordered that allowed us to calculate OGs.

Results: For the prospective study period in 2003, the ROC areas indicated that we could accurately predict the presence of toxic volatiles but at markedly different decision cutpoints depending on the formula used. These cutpoints ranged from +10 to +33 mosmol/kg. In the retrospective study, the mean OGs in the patient population for each of the 3 formulas increased by 12 mosmol/kg from 1996 to 2004. For this reason, the diagnostic accuracy was poor when all data were analyzed together.

Conclusions: Under properly controlled conditions, the OG has high sensitivity and specificity for detection of poisoning with some volatiles. Over the long term, however, use of the reference interval of –10 to +10 mosmol/kg yields poor diagnostic accuracy because mean OGs are not constant over time. Bedside calculation is not advisable.






HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2006 by the American Association for Clinical Chemistry.